These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29201725)

  • 21. Rate and predictors of success in the retreatment of chronic hepatitis C virus in HIV/hepatitis C Virus coinfected patients with prior nonresponse or relapse.
    Labarga P; Vispo E; Barreiro P; Rodríguez-Novoa S; Pinilla J; Morello J; Martín-Carbonero L; Tuma P; Medrano J; Soriano V
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):364-8. PubMed ID: 20101191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of Viral Hepatitis and Liver Diseases in India.
    Bhaumik P
    Euroasian J Hepatogastroenterol; 2015; 5(1):34-36. PubMed ID: 29201683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection.
    Cornberg M; Petersen J; Schober A; Mauss S; Böker KH; Link R; Günther R; Serfert Y; Pfeiffer-Vornkahl H; Manns MP; Sarrazin C; Hüppe D; Berg T; Niederau C
    Aliment Pharmacol Ther; 2017 Mar; 45(5):688-700. PubMed ID: 28078723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of Viral Hepatitis and Liver Diseases in Cambodia.
    Sreng B; Kimcheng H; Sovann LY; Huot E
    Euroasian J Hepatogastroenterol; 2015; 5(1):30-33. PubMed ID: 29201682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral Hepatitis in Indonesia: Past, Present, and Future.
    Mulyanto
    Euroasian J Hepatogastroenterol; 2016; 6(1):65-69. PubMed ID: 29201730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral Hepatitis and Liver Diseases in Mongolia.
    Baatarkhuu O; Uugantsetseg G; Munkh-Orshikh D; Naranzul N; Badamjav S; Tserendagva D; Amarsanaa J; Do Young K
    Euroasian J Hepatogastroenterol; 2017; 7(1):68-72. PubMed ID: 29201776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis in Malaysia: Past, Present, and Future.
    Raihan R
    Euroasian J Hepatogastroenterol; 2016; 6(1):52-55. PubMed ID: 29201726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis.
    Dolatimehr F; Karimi-Sari H; Rezaee-Zavareh MS; Alavian SM; Behnava B; Gholami-Fesharaki M; Sharafi H
    Daru; 2017 Apr; 25(1):11. PubMed ID: 28427463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hepatitis C virus infection in thalassemia.
    Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
    Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization against Viral Hepatitis B: Lessons Learnt from Kingdom of Cambodia.
    Sreng B; Vichit O; Vuthikol Y; Aun C; Samnang C
    Euroasian J Hepatogastroenterol; 2017; 7(1):43-47. PubMed ID: 29201771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Viral Hepatitis in Malaysia: "Where are we now?".
    Raihan R; Mohamed R; Radzi Abu Hassan M; Md Said R
    Euroasian J Hepatogastroenterol; 2017; 7(1):65-67. PubMed ID: 29201775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Sustained Virological Response to Peginterferon-based Therapy for Chronic Hepatitis C: Regression Analysis of a Cohort from Rio Grande do Sul, Brazil.
    V Picon R; Fendt L; Amaral K; D Picon P
    Euroasian J Hepatogastroenterol; 2017; 7(1):27-33. PubMed ID: 29201768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood Hepatitis in Osh Province of Southern Kyrgyzstan.
    Toichuev R; Leybman E; Omorbekova C; Rakhimova G; Zhumabek Kyzy B; Nikolaeva L
    Euroasian J Hepatogastroenterol; 2014; 4(2):117-118. PubMed ID: 29699362
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection.
    Saab S; Gordon SC; Park H; Sulkowski M; Ahmed A; Younossi Z
    Aliment Pharmacol Ther; 2014 Sep; 40(6):657-75. PubMed ID: 25065960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of Viral Hepatitis and Liver Diseases in Nepal.
    Shrestha A
    Euroasian J Hepatogastroenterol; 2015; 5(1):40-42. PubMed ID: 29201685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver Cancer in Nepal.
    Shrestha A
    Euroasian J Hepatogastroenterol; 2018; 8(1):63-65. PubMed ID: 29963465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of Chronic Hepatitis B in Turkey.
    Özkan H
    Euroasian J Hepatogastroenterol; 2018; 8(1):73-74. PubMed ID: 29963468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study.
    Iqbal S; Yousuf MH; Yousaf MI
    World J Gastroenterol; 2017 Nov; 23(44):7899-7905. PubMed ID: 29209131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of Acute Liver Failure from North-east India and Its Differences from other Parts of the Country.
    Das AK; Begum T; Kar P; Dutta A
    Euroasian J Hepatogastroenterol; 2016; 6(2):111-115. PubMed ID: 29201741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection.
    Johnson SJ; Parisé H; Virabhak S; Filipovic I; Samp JC; Misurski D
    J Med Econ; 2016 Oct; 19(10):983-94. PubMed ID: 27172133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.